Siyomicro Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $14.7M

  • Investors
  • 7

Siyomicro General Information

Description

Developer of synthetic biology technologies designed to advance the production of bioactive ingredients and microbial-based products. The company offers microbial enzyme development, extreme-environment microorganism resources, genome databases, and bioactive compounds, enabling pharmaceutical, healthcare, food, and personal care companies to develop biotechnology-based products with enhanced research and manufacturing capabilities.

Contact Information

Website
www.siyobio.com
Formerly Known As
Shenzhen Xinyang Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Precision Digital Culture Industrial Park, C801-C812, Number 39 Qingfeng Avenue
  • Baolong Street, Baolong Community, Longgang District
  • Shenzhen, Guangdong 518116
  • China
+86 134
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Precision Digital Culture Industrial Park, C801-C812, Number 39 Qingfeng Avenue
  • Baolong Street, Baolong Community, Longgang District
  • Shenzhen, Guangdong 518116
  • China
+86 134

Siyomicro Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Siyomicro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C) 26-Jul-2026 $14.7M Completed Generating Revenue
7. Secondary Transaction - Private 08-Aug-2025 Completed Generating Revenue
6. Later Stage VC 27-Dec-2023 Completed Generating Revenue
5. Secondary Transaction - Private 14-Jul-2022 Completed Generating Revenue
4. Later Stage VC (Series B) 07-Feb-2022 Completed Generating Revenue
3. Later Stage VC (Series A1) 01-Jun-2020 Completed Generating Revenue
2. Early Stage VC 28-Sep-2019 Completed Generating Revenue
1. Early Stage VC 01-Jun-2017 Completed Generating Revenue
To view Siyomicro’s complete valuation and funding history, request access »

Siyomicro Patents

Siyomicro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025035987-A1 Preparation and use of high-selectivity adsorption anion resin for ergothioneine Inactive 15-Aug-2023

Siyomicro Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Goldport Capital Venture Capital Minority
Shenzhen Longgang Financial Holding Venture Capital Minority
Aier Eye Hospital Group Corporation Minority
Aier Healthcare Investment Corporate Venture Capital Minority
Aramco Ventures Corporate Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Siyomicro FAQs

  • When was Siyomicro founded?

    Siyomicro was founded in 2015.

  • Where is Siyomicro headquartered?

    Siyomicro is headquartered in Shenzhen, China.

  • What industry is Siyomicro in?

    Siyomicro’s primary industry is Biotechnology.

  • Is Siyomicro a private or public company?

    Siyomicro is a Private company.

  • What is Siyomicro’s current revenue?

    The current revenue for Siyomicro is .

  • How much funding has Siyomicro raised over time?

    Siyomicro has raised $60.2M.

  • Who are Siyomicro’s investors?

    Goldport Capital, Shenzhen Longgang Financial Holding, Aier Eye Hospital Group, Aier Healthcare Investment, and Aramco Ventures are 5 of 7 investors who have invested in Siyomicro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process